Essential drugs in the WHO African Region: situation and trend analysis
Abstract1. WHO's mission in the area of essential drugs is to help reduce morbidity and mortality due to common illnesses by collaborating with the countries of the African Region to develop and implement national drug policies and programmes that will ensure equitable access to and rational use of essential drugs of proven quality. 2. Drugs are important because they help to save lives and to promote trust and participation in health services. Although they are costly, significant improvements in their supply and use are possible with proper management and planning within the context of national drug policies. 3. Changes in the economic, sociopolitical and demographic environment, globalization of trade including in pharmaceuticals, increasing poverty, currency fluctuations, the problem of emerging and re-emerging diseases, disease resistance to existing drugs, and irrational drug use are ail putting an extra burden on already overstretched drug budgets. 4. In the light of the above, there is a need for a renewed commitment to the development and implementation of national drug policies that will ensure an effective increase in access to essential drugs of proven quality. 5. This document gives an overview of the pharmaceutical situation in the African Region with particular focus on ongoing efforts, the challenges to be met and the future perspectives within the context of the Intensified Essential Drugs Programme for the African Region. 6. The Regional Committee is invited to review this document and provide further guidance for the implementation of country and regional programmes in this important domain.
Regional Committee for Africa, 49. (2011). Essential drugs in the WHO African Region: situation and trend analysis. https://apps.who.int/iris/handle/10665/1926